FDA clears Kodak CAD system
Eastman Kodak Health Imaging this week at RSNA announced that it entered the mammography CAD market with the FDA clearance of its mammography computer-aided detection (CAD) system. Shipments are beginning immediately, the company said.
The system consists of a digitizer for input of traditional film mammograms, a computer and CAD software, and a report station with a PC and monitor. It will be sold as a unit, although facilities may purchase additional report stations.
Clinical trial results submitted to the FDA document that 39.4 percent of missed breast cancers could have been detected 14.8 months earlier using Kodak CAD technology, according to the company. Approximately 95 percent of patient mammography images in the U.S are captured on x-ray film, Kodak said.
The system consists of a digitizer for input of traditional film mammograms, a computer and CAD software, and a report station with a PC and monitor. It will be sold as a unit, although facilities may purchase additional report stations.
Clinical trial results submitted to the FDA document that 39.4 percent of missed breast cancers could have been detected 14.8 months earlier using Kodak CAD technology, according to the company. Approximately 95 percent of patient mammography images in the U.S are captured on x-ray film, Kodak said.